FDA has classified the recent recall of Medtronic's MDT StealthStation auto-registration feature for deep brain stimulation (DBS) procedures as Class I due to health risks associated with its use.

Robotic Trajectory Guidance Platform Integrates Multiple Enabling Technologies to Support Complex Cranial Procedures The Stealth Autoguide Platform is cleared for biopsy procedures, ...

If Medtronic is currently experiencing a sense of déjà vu, it’s for good reason. About three years after launching a Class I recall of some of its StealthStation surgical navigation software, the ...

The U.S. Food and Drug Administration classified a software glitch with Medtronic's StealthStation S8 surgical navigation system as a Class I recall, the most serious issued by the agency.

FDA Posts Notice on Medtronic Cranial Software Recall Medtronic recalled Synergy Cranial Software and Stealth Station S7 Cranial Software in September 2018 because of inaccuracies displayed during ...

Medtronic (NYSE:MDT) has recalled its StealthStation S8 Application Version 2.0 and 2.0.1 due to a software glitch that can cause surgical plan data to shift locations, according to the FDA. The ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Medtronic’s Stealth Autoguide is used in surgery for ...

Medtronic completed one of the year's largest acquisitions in orthopedics Wednesday, buying Israel-based Mazor Robotics in a $1.7 billion cash deal that aims to improve spine surgery by providing more ...

Muskegon (Mich.) Surgery Center is the state’s first ASC to use Medtronic’s Mazor X Stealth Edition robotic guidance platform for spine surgery. 1. MSC is the second surgery center in the country to ...

Robotic Trajectory Guidance Platform Integrates Multiple Enabling Technologies to Support Complex Cranial Procedures DUBLIN, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) announced that ...